A Study of Abicipar Pegol in Patients With Diabetic Macular Edema

Completed · Phase 2 · Has a placebo group

Conditions studied: Macular Edema

In brief

This is a safety and efficacy study of abicipar pegol in patients with diabetic macular edema.

Key facts

Study ID

NCT02186119

Run by

Allergan

People needed

151

Starts

2014-07-01

Expected to finish

2015-06-01

Last updated by the study team

2015-07-14

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of diabetes mellitus (Type 1 or 2)
• Decreased vision due to diabetic macular edema in at least 1 eye
• Best corrected visual acuity of 20/32 to 20/320 in the study eye and 20/200 or better in the fellow eye

You may not qualify if…

• Stroke or heart attack within the past 3 months
• History of vitrectomy, macular surgery, or glaucoma surgery in the study eye
• Cataract or refractive surgery in the study eye within the last 3 months
• Laser photocoagulation of the study eye within the last 3 months

Where it is running

• Study site — Gilbert, Arizona, United States
• Study site — Abilene, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.